Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06157892 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 172 participants |
| Active Locations | 73 sites in the US |
| Sponsor | Seagen, a wholly owned subsidiary of Pfizer |
| Last Updated on CT.gov | March 17, 2026 (Mar 17, 2026) |
As of April 18, 2026: Clinical trial NCT06157892 is currently recruiting participants. This clinical trial study for breast cancer is actively seeking new participants at 73 locations across the United States. The study is sponsored by Seagen, a wholly owned subsidiary of Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06157892 is actively recruiting participants as of April 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 73 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06157892 was last updated Mar 17, 2026 (March 17, 2026). HelloStudys verifies this status automatically.